Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 426, 129-131 (13 November 2003) | doi:10.1038/nature02105; Published online 26 October 2003
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
- More Challenges
- Powered by:
nature jobs
Executive- Commercial- Corporate Office
- Rhydburg Pharmaceuticals
- Selaqui-Dehradun India
Two Post-Doctoral Position In Nanomedicine
- Fondazione IRCCS Istituto Neurologico "Carlo Besta" (FINCB)
- Via Celoria n.11, 20133 Milano, Italy
Virology: Fresh assault on hepatitis C
Charles M. Rice1
Abstract
Hepatitis C virus causes severe liver disease. Initial trials of a newly developed agent that prevents the virus reproducing itself look promising. But what are the future prospects for this treatment?
As researchers gradually got to grips with viruses that attack the liver, two were identified early on — hepatitis A and hepatitis B. But clearly there were more, because there were also cases of hepatitis that had the hallmarks of neither virus.
- Center for the Study of Hepatitis C, Laboratory of Virology and Infectious Disease, The Rockefeller University, 1230 York Avenue, New York, New York 10021, USA.
Email: ricec@rockefeller.edu
To read this story in full you will need to login or make a payment (see right).
